US Patent 7943744 ICAM-1 binding antibodies
Patent 7943744 was granted and assigned to BioInvent International on May, 2011 by the United States Patent and Trademark Office.
All edits
Edits on 31 Jul, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Loading...
1Edits on 27 Nov, 2023
Golden AI
Edits made to:
Article (+369 characters)
Article
Patent abstract
The invention provides binding molecules, including antibody molecules which selectively bind to a cell surface antigen of a target cell, and wherein the binding molecules, on binding the cell surface antigen, induce apoptosis of the target cell. There is also provided methods of and pharmaceutical compositions for apoptosis induction and uses thereof.
Edits on 19 Sep, 2023
Golden AI
Edits made to:
Infobox (+2 properties)
Infobox
Patent Inventor Names
Björn Frendéus1
Roland Carlsson1
Edits on 21 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07943744 ICAM-1 binding antibodies US Patent 7943744 ICAM-1 binding antibodies
Infobox
Patent Number
079437441
Patent Number
79437441
Edits on 22 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
079437441
Date of Patent
May 17, 2011
1Patent Application Number
120971931
Date Filed
December 8, 2006
1Patent Primary Examiner
Edits on 7 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07943744 ICAM-1 binding antibodies
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07943744
Date of patent
May 17, 2011
Patent application number
12097193
Date Filed
December 8, 2006
Patent primary examiner
Find more entities like US Patent 7943744 ICAM-1 binding antibodies
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
